CLN8 抗体 (AA 247-286)
-
- 抗原 See all CLN8 抗体
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
-
抗原表位
- AA 247-286
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CLN8 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC)
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human Protein CLN8 protein (247-286AA)
- 亚型
- IgG
- Top Product
- Discover our top product CLN8 Primary Antibody
-
-
- 应用备注
- Recommended dilution: IHC:1:20-1:200,
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- CLN8 (Ceroid-Lipofuscinosis, Neuronal 8 (Epilepsy, Progressive with Mental Retardation) (CLN8))
- 别名
- CLN8 (CLN8 产品)
- 别名
- mnd antibody, C8orf61 antibody, EPMR antibody, CLN8, transmembrane ER and ERGIC protein antibody, ceroid-lipofuscinosis, neuronal 8 antibody, CLN8 antibody, Cln8 antibody
- 背景
-
Background: Could play a role in cell proliferation during neuronal differentiation and in protection against cell death.
Aliases: CLN8 antibody, C8orf61 antibody, Protein CLN8 antibody
- UniProt
- Q9UBY8
- 途径
- Regulation of Cell Size, Dicarboxylic Acid Transport
-